Abuse-related effects of μ-opioid analgesics in an assay of intracranial self-stimulation in rats: Modulation by chronic morphine exposure

Behavioural Pharmacology

Volumn 24, Issue 5-6, 2013, Pages 459-470

  Altarifi, Ahmad A ^a,c   Rice, Kenner C ^b   Negus, S Stevens ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

chronic morphine; drug abuse; fentanyl; intracranial self stimulation; methadone; nalbuphine; rat; tolerance

Indexed keywords

FENTANYL; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NALBUPHINE; NALTREXONE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; DRUG EXPOSURE; ELECTRODE IMPLANT; INTRACRANIAL SELF STIMULATION; MALE; MEDIAL FOREBRAIN BUNDLE; MORPHINE ADDICTION; NONHUMAN; RAT; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, OPERANT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; MALE; MEDIAL FOREBRAIN BUNDLE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SELF STIMULATION; SUBSTANCE-RELATED DISORDERS;

EID: 84881555416     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328364c0bd     Document Type: Article

References (43)

1. Altarifi AA, Negus SS (2011). Some determinants of morphine effects on intracranial self-stimulation in rats: Dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharmacol 22:663-673
2. Altarifi AA, Miller LL, Negus SS (2012). Role of micro-opioid receptor reserve and micro-Agonist efficacy as determinants of the effects of micro-Agonists on intracranial self-stimulation in rats. Behav Pharmacol 23:678-692
3. Bauer CT, Banks ML, Blough BE, Negus SS (2013). Use of intracranial selfstimulation to evaluate abuse-related and abuse-Limiting effects of monoamine releasers in rats. Br J Pharmacol 168:850-862
4. Broekkamp CL, Van den Bogaard JH, Heijnen HJ, Rops RH, Cools AR, Van Rossum JM (1976). Separation of inhibiting and stimulating effects of morphine on self-stimulation behaviour by intracerebral microinjections. Eur J Pharmacol 36:443-446
5. Carlezon WA Jr, Wise RA (1993). Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res 620:339-342
6. Carlezon WA Jr, Chartoff EH (2007). Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987-2995
7. Carrera MR, Schulteis G, Koob GF (1999). Heroin self-Administration in dependent Wistar rats: Increased sensitivity to naloxone. Psychopharmacology (Berl) 144:111-120
8. Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Munoz A (2007). The development of a comprehensive risk-management program for prescription opioid analgesics: Researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med 8:157-170
9. Comer SD, Sullivan MA, Vosburg SK, Kowalczyk WJ, Houser J (2010). Abuse liability of oxycodone as a function of pain and drug use history. Drug Alcohol Depend 109:130-138
10. Cooper ZD, Sullivan MA, Vosburg SK, Manubay JM, Haney M, Foltin RW, et al. (2012). Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers. Behav Pharmacol 23:271-279
11. Denisco RA, Chandler RK, Compton WM (2008). Addressing the intersecting problems of opioid misuse and chronic pain treatment. Exp Clin Psychopharmacol 16:417-428
12. Easterling KW, Holtzman SG (1997). Intracranial self-stimulation in rats: Sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists. J Pharmacol Exp Ther 281:188-199
13. Gringauz M, Rabinowitz R, Stav A, Korczyn AD (2001). Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and crosstolerance to morphine. J Anesth 15:204-209
14. Hughes CE, Picker MJ, Dykstra LA (1995). Tolerance and cross-Tolerance to the response rate-Decreasing effects of micro opioids in morphine-maintained squirrel monkeys. Behav Pharmacol 6:776-784
15. Hursh SR,Winger G (1995). Normalized demand for drugs and other reinforcers. J Exp Anal Behav 64:373-384
16. Kishioka S, Inoue N, Nishida S, Fukunaga Y, Yamamoto H (1996). Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats. Eur J Pharmacol 316:7-14
17. Kornetsky C, Esposito RU, McLean S, Jacobson JO (1979). Intracranial selfstimulation thresholds: A model for the hedonic effects of drugs of abuse. Arch Gen Psychiatry 36:289-292
18. Lasagna L, Von Felsinger JM, Beecher HK (1955). Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts. J Am Med Assoc 157:1006-1020
19. Lett BT (1989). Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98:357-362
20. Liu J, Pan H, Gold MS, Derendorf H, Bruijnzeel AW (2008). Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats. Neuropharmacology 55:812-818
21. Lorens SA, Mitchell CL (1973). Influence of morphine on lateral hypothalamic self-stimulation in the rat. Psychopharmacologia 32:271-277
22. Miliaressis E, Rompre PP, Laviolette P, Philippe L, Coulombe D (1986). The curve-shift paradigm in self-stimulation. Physiol Behav 37:85-91
23. Negus SS, Rice KC (2009). Mechanisms of withdrawal-Associated increases in heroin self-Administration: Pharmacologic modulation of heroin vs food choice in heroin-Dependent rhesus monkeys. Neuropsychopharmacology 34:899-911
24. Oliveto AH, Picker MJ, Dykstra LA (1991). Acute and chronic morphine administration: Effects of mixed-Action opioids in rats and squirrel monkeys responding under a schedule of food presentation. J Pharmacol Exp Ther 257:8-18
25. Picker MJ, Yarbrough J (1991). Cross-Tolerance and enhanced sensitivity to the response rate-Decreasing effects of opioids with varying degrees of efficacy at the mu receptor. Psychopharmacology (Berl) 105:459-466
26. Picker MJ, Negus SS, Powell KR (1991). Differential cross-Tolerance to mu and kappa opioid agonists in morphine-Tolerant rats responding under a schedule of food presentation. Psychopharmacology (Berl) 103:129-135
27. Pitts RC,West JP, Morgan D, Dykstra LA, Picker MJ (1996). Opioids and rate of positively reinforced behavior: Differential antagonism by naltrexone. Behav Pharmacol 7:205-215
28. Preston KL, Bigelow GE, Liebson IA (1989). Antagonist effects of nalbuphine in opioid-Dependent human volunteers. J Pharmacol Exp Ther 248:929-937
29. Rowlett JK, Rodefer JS, Spealman RD (2002). Self-Administration of cocaine, alfentanil, and nalbuphine under progressive-ratio schedules: Consumer demand and labor supply analyses of relative reinforcing effectiveness. Exp Clin Psychopharmacol 10:367-375
30. Selley DE, Liu Q, Childers SR (1998). Signal transduction correlates of mu opioid agonist intrinsic efficacy: Receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther 285:496-505
31. Shippenberg TS, Heidbreder C, Lefevour A (1996). Sensitization to the conditioned rewarding effects of morphine: Pharmacology and temporal characteristics. Eur J Pharmacol 299:33-39
32. Sim LJ, Selley DE, Dworkin SI, Childers SR (1996). Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci 16:2684-2692
33. Smith MA, Pitts RC, Picker MJ (1997). Tolerance and cross tolerance to the accuracy-And rate-Decreasing effects of mu opioids in rats responding under a fixed-consecutive-number schedule. Drug Alcohol Depend 46: 19-30
34. Spanagel R, Shippenberg TS (1993). Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat. Neurosci Lett 153: 232-236
35. Thompson T, Schuster CR (1964). Morphine self-Administration, food-reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacologia 5: 87-94
36. Vlachou S, Markou A (2010). The use of the intracranial self-stimulation in drug abuse research: Addictive drugs and neurobiology of reward and motivation. In: Olmstead MC, editor. Animal models of drug addiction. New York: Springer; p. 53
37. Walker DJ, Zacny JP, Galva KE, Lichtor JL (2001). Subjective, psychomotor, and physiological effects of cumulative doses of mixed-Action opioids in healthy volunteers. Psychopharmacology (Berl) 155:362-371
38. Walker EA, Richardson TM, Young AM (1997). Tolerance and cross-Tolerance to morphine-Like stimulus effects of mu opioids in rats. Psychopharmacology (Berl) 133:17-28
39. Wise RA (1998). Drug-Activation of brain reward pathways. Drug Alcohol Depend 51:13-22
40. Woods JH, Gmerek DE (1985). Substitution and primary dependence studies in animals. Drug Alcohol Depend 14:233-247
41. Yanagita T (1978). Drug dependence studies in laboratory animals. NIDA Res Monogr 19:179-190
42. Young AM, Kapitsopoulos G, Makhay MM (1991a). Tolerance to morphine-Like stimulus effects of mu opioid agonists. J Pharmacol Exp Ther 257:795-805
43. Young AM, Steigerwald ES, Makhay MM, Kapitsopoulos G (1991b). Onset of tolerance to discriminative stimulus effects of morphine. Pharmacol Biochem Behav 39:487-493